Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 16/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 12/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 9/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 7/20 | 0.38 |
| ▸ | MEN1 | O00255 | 5/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.38 |
| ▸ | CASP1 | P29466 | 3/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 5/20 | 0.37 |
| ▸ | USP2 | O75604 | 6/20 | 0.35 |
| ▸ | GLA | P06280 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 4/20 | 0.34 |
| ▸ | CASP7 | P55210 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.33 |
| ▸ | HASPIN | Q8TF76 | 1/20 | 0.33 |
| ▸ | BRAF | P15056 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21514130 | 1.00 | CYP1A2 (0.42) | CYP1A2ALDH1A1CYP3A4HSD17B10MEN1 | |
| SCHEMBL29882295 | 0.83 | KRAS (0.34) | CYP1A2ALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL21514180 | 0.83 | KRAS (0.34) | CYP1A2ALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL21514178 | 0.83 | TSHR (0.38) | CYP1A2ALDH1A1CYP3A4HSD17B10CASP1 | |
| SCHEMBL29882178 | 0.83 | TSHR (0.38) | CYP1A2ALDH1A1CYP3A4HSD17B10CASP1 | |
| SCHEMBL21514670 | 0.80 | ALDH1A1 (0.50) | CYP1A2ALDH1A1CYP3A4HSD17B10MEN1 | |
| SCHEMBL29883025 | 0.80 | ALDH1A1 (0.50) | CYP1A2ALDH1A1CYP3A4HSD17B10MEN1 | |
| SCHEMBL21514306 | 0.77 | CYP1A2 (0.52) | CYP1A2ALDH1A1CYP3A4HSD17B10MEN1 | |
| SCHEMBL21514297 | 0.72 | CYP1A2 (0.42) | CYP1A2ALDH1A1CYP3A4HSD17B10MEN1 | |
| SCHEMBL29882244 | 0.72 | CYP1A2 (0.42) | CYP1A2ALDH1A1CYP3A4HSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220274979-A1 | 2-METHYL-AZA-QUINAZOLINES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2022-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220274979-A1 | 2-METHYL-AZA-QUINAZOLINES | AZI2, DNMT1, TPMT | CYP1A2 118/4885ALDH1A1 1232/4885CYP3A4 544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.